Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cost of Goods | N/A | N/A | 50,764 | 45,517 | 33,783 |
| Gross Profit | N/A | N/A | -50,764 | -45,517 | -33,783 |
| Operating Expenses | 172,984 | 127,376 | 5,883 | -2,957 | 4,226 |
| Operating Income | -172,984 | -127,376 | -56,647 | -42,560 | -38,009 |
| Interest Expense | 12,431 | 13,826 | 3,696 | 3,151 | 2,062 |
| Other Income | 9,173 | -6,538 | -13,980 | 150 | -56 |
| Pre-tax Income | -176,242 | -147,740 | -74,323 | -45,561 | -40,127 |
| Income Tax | 0 | 0 | -4,476 | -4,204 | -2,575 |
| Net Income Continuous | -176,242 | -147,740 | -69,847 | -41,357 | -37,552 |
| Net Income | $-176,242 | $-147,740 | $-69,846 | $-41,357 | $-37,551 |
| EPS Basic Total Ops | -2.80 | -3.43 | -2.62 | -2.47 | -1.55 |
| EPS Basic Continuous Ops | -2.80 | -3.43 | -2.62 | -2.47 | -1.55 |
| EPS Diluted Total Ops | -2.80 | -3.43 | -2.62 | -2.47 | -1.55 |
| EPS Diluted Continuous Ops | -2.80 | -3.43 | -2.62 | -2.47 | -1.55 |
| EBITDA(a) | $-162,711 | $-133,207 | $-70,318 | $-42,254 | $-37,999 |